OnKure Therapeutics, Inc. — SC 13D/A Filings
7 SC 13D/A filings on record
This page lists all SC 13D/A filings submitted to the SEC by OnKure Therapeutics, Inc. (OKUR), sorted by most recent first. Each row links to the full filing on EdgarLookup. OnKure Therapeutics, Inc. has filed 7 SC 13D/A documents with the SEC since 2018. To view all SEC filings by OnKure Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
144
3
3/A
4
4/A
424B3
424B4
424B5
425
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
EFFECT
POS AM
S-1
S-1/A
S-3
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13D/A | NEW ENTERPRISE ASSOCIATES 15, L.P. / ONKURE THERAPEUTICS, INC. -- SCHEDULE 13D/A | 0001072613-24-000769 | Oct 8, 2024 | — |
| SC 13D/A | NEW ENTERPRISE ASSOCIATES 15, L.P. / RENEO PHARMA -- SCHEDULE 13D/A(#1) | 0001072613-24-000437 | May 8, 2024 | — |
| SC 13D/A | SC 13D/A | 0001193125-23-296752 | Dec 15, 2023 | — |
| SC 13D/A | SC 13D/A | 0001193125-23-156675 | May 30, 2023 | — |
| SC 13D/A | SC 13D/A | 0001193125-23-145205 | May 15, 2023 | — |
| SC 13D/A | SC 13D/A | 0001193125-22-255621 | Sep 30, 2022 | — |
| SC 13D/A | SC 13D/A | 0001193125-22-019678 | Jan 27, 2022 | — |